During the past decade, Lipid and Diabetes Research Group conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lipid and Diabetes Research Group" #1 sponsor was "Arrowhead Pharmaceuticals" with 3 trials, followed by "DiObex" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "CSL Behring" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lipid and Diabetes Research Group" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lipid and Diabetes Research Group" are "Cardiovascular Disease" (2 trials), "Hypertriglyceridemia" (2 trials), "Type 2 Diabetes" (2 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetic Kidney Disease" (1 trials). Many other conditions were trialed in "Lipid and Diabetes Research Group" in a lesser frequency.

Most popular intervention types in "Lipid and Diabetes Research Group" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ARO-APOC3" (2 trials), "DIO-902" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "sterile normal saline (0.9% NaCl)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lipid and Diabetes Research Group" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Lipid and Diabetes Research Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Lipid and Diabetes Research Group, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lipid and Diabetes Research Group, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".